{"transactions":[{"id":4620393,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option is fully vested."}],"balance_after":50000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-07-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":4620392,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":62150,"price":9.123,"value":566994.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 06-15-2026"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.2, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":56700,"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":4620391,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":2.93,"value":146500.0,"ownership":{"direct":true},"balance_after":118850,"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":737658,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:07:40.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":68850,"source":{"system":"sec-edgar","filing":"0001437749-26-020702","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020702/rdgdoc.xml","form_type":"4"}},{"id":940674,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-13T01:54:54.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs vest on January 12, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs vest on January 12, 2027."}],"balance_after":7700,"derivative":{"exercise_date":"2027-01-12","expiration_date":"2027-01-12","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001193125-26-010856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000119312526010856/ownership.xml","form_type":"4"}},{"id":940673,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T01:54:54.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on January 12, 2027."}],"balance_after":11500,"derivative":{"exercise_price":23.16,"exercise_date":"2027-01-12","expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001193125-26-010856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000119312526010856/ownership.xml","form_type":"4"}},{"id":945697,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:39:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3219,"price":8.76,"value":28198.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":3219,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":3219},"source":{"system":"sec-edgar","filing":"0001827015-26-000002","document":"wk-form4_1767742793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701526000002/wk-form4_1767742793.xml","form_type":"4"}},{"id":945696,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:39:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001827015-26-000002","document":"wk-form4_1767742793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701526000002/wk-form4_1767742793.xml","form_type":"4"}},{"id":1083306,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-22T23:51:39.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.367,"value":90909.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03-11-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":41850,"source":{"system":"sec-edgar","filing":"0001437749-25-023268","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925023268/rdgdoc.xml","form_type":"4"}},{"id":1107815,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:41:27.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":12150,"price":3.4,"value":41310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03-11-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":68850,"source":{"system":"sec-edgar","filing":"0001437749-25-020711","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020711/rdgdoc.xml","form_type":"4"}},{"id":1111406,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:10:12.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001437749-25-020357","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020357/rdgdoc.xml","form_type":"4"}},{"id":1309724,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:17:50.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":3073,"price":9.18,"value":28210.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":3073,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":3073},"source":{"system":"sec-edgar","filing":"0001599298-25-000026","document":"wk-form4_1736209060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000026/wk-form4_1736209060.xml","form_type":"4"}},{"id":1309723,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:17:50.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000026","document":"wk-form4_1736209060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000026/wk-form4_1736209060.xml","form_type":"4"}},{"id":1333384,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-12T23:01:25.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 10, 2024."}],"balance_after":31000,"derivative":{"exercise_price":13.06,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000950170-24-135932","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000095017024135932/ownership.xml","form_type":"4"}},{"id":1471911,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:16:40.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-24-021012","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021012/rdgdoc.xml","form_type":"4"}},{"id":1558401,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Options","published_at":"2024-03-28T12:25:20.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest and become exercisable over four years as follows: (i) 25% of the underlying shares vest one year after the grant date; and (ii) 75% of the remaining underlying shares vest in equal monthly installments over the following three years."}],"balance_after":200000,"derivative":{"exercise_price":9.04,"exercise_date":"2025-03-25","expiration_date":"2034-03-25","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950172-24-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017224000129/form4.xml","form_type":"4"}},{"id":1651137,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T23:15:07.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest in 36 equal monthly installments starting one month after grant date of February 8, 2024."}],"balance_after":74000,"derivative":{"exercise_price":11.47,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0000950170-24-013427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000095017024013427/ownership.xml","form_type":"4"}},{"id":1686968,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:33:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":21363,"price":1.32,"value":28199.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":56363,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":21363},"source":{"system":"sec-edgar","filing":"0001599298-24-000017","document":"wk-form4_1704404000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000017/wk-form4_1704404000.xml","form_type":"4"}},{"id":1686967,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:33:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000017","document":"wk-form4_1704404000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000017/wk-form4_1704404000.xml","form_type":"4"}},{"id":1854145,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T00:10:51.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-23-017590","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017590/rdgdoc.xml","form_type":"4"}},{"id":2061711,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:17:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":16350,"price":1.67,"value":27304.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $27,250."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":51350,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":16350},"source":{"system":"sec-edgar","filing":"0001827015-23-000003","document":"wf-form4_167295342532705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701523000003/wf-form4_167295342532705.xml","form_type":"4"}},{"id":2061710,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:17:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001827015-23-000003","document":"wf-form4_167295342532705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701523000003/wf-form4_167295342532705.xml","form_type":"4"}},{"id":2111535,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:27:59.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":4166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on November 15, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022."}],"balance_after":204166,"derivative":{"exercise_price":1.09,"expiration_date":"2032-11-15","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001599298-22-000127","document":"wf-form4_166872044673174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000127/wf-form4_166872044673174.xml","form_type":"4"}},{"id":2111534,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:27:59.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on November 15, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 15, 2023."}],"balance_after":200000,"derivative":{"exercise_price":1.09,"expiration_date":"2032-11-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-22-000127","document":"wf-form4_166872044673174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000127/wf-form4_166872044673174.xml","form_type":"4"}},{"id":2128441,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-01T11:05:20.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth vests after 12 months from the date of grant with the remaining three-fourths vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month anniversary thereafter."}],"balance_after":90000,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-29","underlying":"Common Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-054967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919122054967/doc4.xml","form_type":"4"}},{"id":2197496,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2022-08-02T21:07:16.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The vesting commencement date of the option is July 29, 2022 (the \"Option Vesting Commencement Date\"). Subject to the Reporting Person's continued service with the Issuer through the applicable vesting date, the option vests (i) on the first anniversary of the Option Vesting Commencement Date with respect to one-third (1/3rd) of the shares subject thereto and (ii) on each monthly anniversary of the Option Vesting Commencement Date thereafter with respect to an additional 1/36th of the shares subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date of the option is July 29, 2022 (the \"Option Vesting Commencement Date\"). Subject to the Reporting Person's continued service with the Issuer through the applicable vesting date, the option vests (i) on the first anniversary of the Option Vesting Commencement Date with respect to one-third (1/3rd) of the shares subject thereto and (ii) on each monthly anniversary of the Option Vesting Commencement Date thereafter with respect to an additional 1/36th of the shares subject thereto."}],"balance_after":100000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-07-28","underlying":"COMMON STOCK","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-22-018468","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922018468/rdgdoc.xml","form_type":"4"}},{"id":2910983,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:43:37.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter."}],"balance_after":57500,"derivative":{"exercise_price":7,"expiration_date":"2030-12-11","underlying":"Common Shares","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001209191-21-002946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002946/doc4.xml","form_type":"4"}}]}